Production (Stage)
OnKure Therapeutics, Inc.
OKUR
$2.88
$0.020.70%
NASDAQ
| 03/31/2025 | 12/31/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 402.19% | 270.74% | -- | 66.75% | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -56.33% | -42.37% | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 332.32% | 234.67% | -- | -- | |
|
|
|||||
| Total Current Assets | 332.32% | 234.67% | -- | -- | |
| Net Property, Plant & Equipment | -9.45% | -6.02% | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 113.73% | 87.93% | -- | -- | |
| Total Assets | 307.23% | 221.56% | -- | -- | |
|
|
|||||
| Total Accounts Payable | -35.30% | -13.14% | -- | -- | |
| Total Accrued Expenses | 243.53% | 91.97% | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 157.55% | 157.69% | -- | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 58.26% | 44.54% | -- | -- | |
|
|
|||||
| Total Current Liabilities | 58.26% | 44.54% | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -0.73% | 17.81% | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 54.85% | 42.94% | -- | -- | |
|
|
|||||
| Common Stock & APIC | 80,052.45% | 123,609.09% | -- | -- | |
| Retained Earnings | -52.93% | -51.61% | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 181.47% | 201.95% | -- | -104.46% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | 101.63% | |
|
|
|||||
| Total Common Equity | 181.47% | 201.95% | -- | -104.46% | |
| Total Preferred Equity | -- | -- | -- | 101.63% | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 388.30% | 271.04% | -- | 86.18% | |
|
|
|||||